REYON Pharmaceutical Co., Ltd.
Research REYON Pharmaceutical Co., Ltd. (102460.KS) on Bullrun: market cap KRW 181.94B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker102460.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 181.94B
- Financial periodQ2 2026
- RevenueKRW 35.85B
- Net income-KRW 6.80B
- Free cash flowKRW 7.98B
- Gross margin25.8%
Valuation Snapshot
latest market cap is KRW 181.94B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 181.94B | n/a | n/a | n/a |
About REYON Pharmaceutical Co., Ltd.
REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants;
ETFs that hold REYON Pharmaceutical Co., Ltd.
US-listed ETFs
REYON Pharmaceutical Co., Ltd. is held by 4 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets ex China Core Equity ETF (DEXC) | <0.01% | 0.43% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is REYON Pharmaceutical Co., Ltd.'s market cap?
REYON Pharmaceutical Co., Ltd.'s market capitalization is KRW 181.94B.
What does REYON Pharmaceutical Co., Ltd. do?
REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular.